OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
53
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Publication Date
Release Date
2022
(12)
2021
(11)
2023
(9)
2024
(4)
2018
(4)
2010
(4)
2025
(2)
2016
(2)
2020
(1)
2019
(1)
2015
(1)
2011
(1)
2008
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA).
Not available
S-EPMC6700053
|
biostudies-literature
Cite
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Not available
S-EPMC11175705
|
biostudies-literature
Cite
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Not available
S-EPMC9447373
|
biostudies-literature
Cite
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.
Not available
S-EPMC8026396
|
biostudies-literature
Cite
Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.
Not available
S-EPMC4698022
|
biostudies-literature
Cite
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233
|
biostudies-literature
Cite
Maternal Black Race and Persistent Wheezing Illness in Former Extremely Low Gestational Age Newborns: Secondary Analysis of a Randomized Trial.
Not available
S-EPMC6019148
|
biostudies-literature
Cite
Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort.
Not available
S-EPMC4432819
|
biostudies-literature
Cite
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.
Not available
S-EPMC9669819
|
biostudies-literature
Cite
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Not available
S-EPMC8700279
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets